UK
Umang Kanoria
About Umang Kanoria
Data last updated:
Umang Kanoria is a Director at Cesc Ltd (since 2026), Director at Pcbl Chemical Limited (since 2024) and Director at Aquapharm Chemical Limited (since 2026), and holds 8 more current directorships. The companies operate in Energy and Power, Metals and Minerals and Wood. The 11 current companies with reported revenue have a combined latest revenue of ₹29,159 Cr; the largest is Cesc Ltd at ₹18,927 Cr (FY 2026). Earlier, Umang Kanoria was a Director at Harrisons Malayalam Ltd (2004–2015) and Additional Director at Saregama India Limited (2015–2016) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Feb 2026 | 1978 | ₹18,927 Cr (FY 2026) | Active | |
| Director | 09 Oct 2024 | 1960 | ₹8,452 Cr (FY 2025) | Active | |
| Director | 31 Mar 2026 | 2024 | ₹1,431 Cr (FY 2025) | Active | |
| Director | 03 Aug 2021 | 2009 | ₹245 Cr (FY 2025) | Active | |
| Managing Director | 23 Sep 2013 | 1983 | ₹68.23 Cr (FY 2025) | Active | |
| Director | 16 Jun 2022 | 2022 | ₹18.76 Cr (FY 2025) | Active | |
| Director | 28 Jan 2003 | 1897 | ₹15.23 Cr (FY 2025) | Active | |
| Managing Director | 08 Jul 1997 | 1991 | ₹1.03 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Aug 2004 | 1978 | ₹526 Cr (FY 2025) | Active | |
| Additional Director | 28 Sep 2015 | 1946 | ₹1,027 Cr (FY 2026) | Active | |
| Director | 30 Dec 2010 | 1990 | ₹21.91 Cr (FY 2025) | Active | |
| Additional Director | 19 Jun 2015 | 2011 | ₹1.17 Cr (FY 2025) | Active | |
| Director | 22 Apr 1991 | 1990 | ₹32.7 Lakh (FY 2018) | Amalgamated | |
| Director | 19 Jul 2013 | 1929 | ₹21.13 Cr (FY 2025) | Active | |
| Director | 07 Sep 2006 | 1991 | ₹5.3 Lakh (FY 2018) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Umang Kanoria
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Umang Kanoria
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umang Kanoria
Umang Kanoria currently holds 11 directorships: Cesc Ltd (Director, since 25 Feb 2026, revenue ₹18,927 Cr (FY 2026)); Pcbl Chemical Limited (Director, since 09 Oct 2024, revenue ₹8,452 Cr (FY 2025)); Aquapharm Chemical Limited (Director, since 31 Mar 2026, revenue ₹1,431 Cr (FY 2025)); Woodlands Multispeciality Hospital Limited (Director, since 03 Aug 2021, revenue ₹245 Cr (FY 2025)); Kanco Tea & Industries Limited (Managing Director, since 23 Sep 2013, revenue ₹68.23 Cr (FY 2025)); and 6 more.
Umang Kanoria was first appointed on 22 Apr 1991 as Director at S T Investment Private Limited. The most recent appointment on record is 31 Mar 2026 at Aquapharm Chemical Limited.
The 11 current companies of Umang Kanoria that report revenue have a combined latest revenue of ₹29,159 Cr: Cesc Ltd ₹18,927 Cr (FY 2026); Pcbl Chemical Limited ₹8,452 Cr (FY 2025); Aquapharm Chemical Limited ₹1,431 Cr (FY 2025); Woodlands Multispeciality Hospital Limited ₹245 Cr (FY 2025); Kanco Tea & Industries Limited ₹68.23 Cr (FY 2025); and 6 more.
Umang Kanoria held 7 earlier board appointments: Harrisons Malayalam Ltd (Director, 19 Aug 2004 to 14 May 2015); Saregama India Limited (Additional Director, 28 Sep 2015 to 22 Jul 2016); Stel Holdings Limited (Director, 30 Dec 2010 to 30 Sep 2019); Jemini Vincom Private Limited (Additional Director, 19 Jun 2015 to 30 Sep 2015); S T Investment Private Limited (Director, 22 Apr 1991 to 26 Mar 2011); and 2 more.
The current boards of Umang Kanoria's companies include Arjun Kumar (Cesc Ltd), Brajesh Singh (Cesc Ltd), Debanjan Mandal (Cesc Ltd), Jagdish Patra (Cesc Ltd), Kusum Dadoo (Cesc Ltd), Paras Kumar Chowdhary (Cesc Ltd), among others.